APA (7th ed.) Citation

Dennie, J., Vandell, A. G., Inoue, S., Gajee, R., Pav, J., Zhang, G., . . . Senaldi, G. (2018). A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor. Journal of clinical pharmacology, 58(12), 1557. https://doi.org/10.1002/jcph.1151

Chicago Style (17th ed.) Citation

Dennie, Justin, et al. "A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor." Journal of Clinical Pharmacology 58, no. 12 (2018): 1557. https://doi.org/10.1002/jcph.1151.

MLA (9th ed.) Citation

Dennie, Justin, et al. "A Phase I, Single-Ascending-Dose Study in Healthy Subjects to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DS-2969b, a Novel GyrB Inhibitor." Journal of Clinical Pharmacology, vol. 58, no. 12, 2018, p. 1557, https://doi.org/10.1002/jcph.1151.